Janssen Search
Search results
Global Public Health Leaders
JANSSEN LEADERSHIP IN GLOBAL PUBLIC HEALTH At Janssen, we have a single overarching mission: to address and solve the most important unmet medical needs of our time. Our commitment to global public health is an important contribution toward achieving ...
Sharing Our Learnings
Sharing Our Learnings It is our mission to share key learnings on how to objectively, fairly and ethically approach compassionate use requests and advance public health. CompAC is a model that has the potential for wider application within the industry. ...
JCI Initiatives
JCI Initiatives Sep 02, 2020 Subhead: Lorem ipsum dolor sit amet, consectetuer adipiscing elit By combining the agility of a lean team, the resources and industry-leading position of Janssen, and the expertise and reach of innovative collaborators, JCI ...
Johnson & Johnson highlights innovation in hemolytic disease of the fetus and newborn (HDFN) at the Society for Maternal-Fetal Medicine’s (SMFM) 2024 Pregnancy Meeting
Feb 09, 2024 United States Presentations include additional analyses of nipocalimab data from pregnancies at risk for early-onset severe HDFN; Nipocalimab is the only anti-FcRn being studied in this rare and potentially life-threatening two-person disease ...
Vaccines: The Heroes of Public Health
Vaccines: The Heroes of Public Health This year’s World Immunization Week, themed, ‘ Protected Together: Vaccines Work! ’ celebrates ‘Vaccine Heroes’ from around the world. It gives us a moment to consider the significant leaps forward we have made as a ...
Strength in Numbers: How Data Science is Unlocking Innovation, and Transforming the Way We Prevent, Treat and Cure Disease
Strength in Numbers: How Data Science is Unlocking Innovation, and Transforming the Way We Prevent, Treat and Cure Disease When most people hear the term 'data science,' they probably think of people sitting at their laptops feverishly ...
Neurodegenerative Disorders: Utilizing biomarker sciences to drive disease understanding, patient identification, and accelerated development
Neurodegenerative Disorders: Utilizing biomarker sciences to drive disease understanding, patient identification, and accelerated development We are in the midst of a scientific renaissance in neurodegeneration, driven by growing evidence of overarching ...
Research & Development
R&D Focus Areas The R&D Leadership Team Transparency of Clinical Trial Data Clinical Trials Careers in Research & Development Cracking the Genetic Code Artificial Intelligence Our Approach to R&D Janssen Storytellers: The Journey Forward ...
Infectious Disease Treatment Development
Development Article Type: Infectious Diseases & Vaccines Exploring the potential of multiple treatment combinations to make a difference in patients' lives The Janssen Infectious Diseases & Vaccines multidisciplinary development team, ...
Neil Davie, Ph.D.
NEIL DAVIE, Ph.D. HEAD, LATE DEVELOPMENT CARDIOVASCULAR, METABOLISM & PULMONARY HYPERTENSION Neil Davie, Ph.D. is the Head, Late Development, of Cardiovascular, Metabolism, & Pulmonary Hypertension (CVM & PH). He has extensive experience as a ...